BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16439052)

  • 1. Role of transurethral resection of the prostate and biopsy of the peripheral zone in the same session after repeated negative biopsies in the diagnosis of prostate cancer.
    Puppo P; Introini C; Calvi P; Naselli A
    Eur Urol; 2006 May; 49(5):873-8. PubMed ID: 16439052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transition zone sampling by TURP in patients with raised PSA and multiple negative transrectal ultrasound-guided prostatic biopsies.
    Radhakrishnan S; Dorkin TJ; Sheikh N; Greene DR
    Prostate Cancer Prostatic Dis; 2004; 7(4):338-42. PubMed ID: 15365579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies.
    Philip J; Dutta Roy S; Scally J; Foster CS; Javlé P
    Prostate; 2005 Jul; 64(2):200-2. PubMed ID: 15712218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of transurethral resection of the prostate in "asymptomatic" patients with an elevated prostate-specific antigen level.
    van Renterghem K; Van Koeveringe G; Achten R; Van Kerrebroeck P
    Eur Urol; 2007 Sep; 52(3):819-26. PubMed ID: 17418482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
    Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
    J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcome of diagnostic transurethral resection of the prostate in patients with elevated prostate-specific antigen level and minor lower urinary tract symptoms.
    van Renterghem K; van Koeveringe G; Achten R; van Kerrebroeck P
    Urol Int; 2009; 83(1):60-5. PubMed ID: 19641361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of serum total and free prostate-specific antigen (PSA) after extended multisite prostate biopsy: Comparison among biopsy, transurethral resection of the prostate (TURP), and biopsy plus TURP.
    Hara N; Koike H; Nobushita T; Miyajima N; Kawaguchi M; Nishiyama T; Takahashi K; Hohenfellner R
    Urol Oncol; 2010; 28(4):355-9. PubMed ID: 19110451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J; Hanchanale V; Foster CS; Javlé P
    BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered prostate specific antigen reference range after transurethral resection of the prostate.
    Wolff JM; Boekels O; Borchers H; Jakse G; Rohde D
    Anticancer Res; 2000; 20(6D):4977-80. PubMed ID: 11326651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-intensity focused ultrasound therapy for clinically localized prostate cancer.
    Lee HM; Hong JH; Choi HY
    Prostate Cancer Prostatic Dis; 2006; 9(4):439-43. PubMed ID: 16847468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.
    Al Otaibi M; Ross P; Fahmy N; Jeyaganth S; Trottier H; Sircar K; Bégin LR; Souhami L; Kassouf W; Aprikian A; Tanguay S
    Cancer; 2008 Jul; 113(2):286-92. PubMed ID: 18484590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
    Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
    Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 mutation in prostate needle biopsies--comparison with patients follow-up.
    Ecke TH; Schlechte HH; Hübsch A; Lenk SV; Schiemenz K; Rudolph BD; Miller K
    Anticancer Res; 2007; 27(6B):4143-8. PubMed ID: 18225585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
    Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
    Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of the role of transurethral resection of the prostate in patients with an elevated prostate-specific antigen level, minor lower urinary tract symptoms, and proven bladder outlet obstruction.
    van Renterghem K; Van Koeveringe G; Achten R; van Kerrebroeck P
    Eur Urol; 2008 Dec; 54(6):1385-92. PubMed ID: 18599187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined use of TUVP and TURP for prostate cancer with bladder outlet obstruction].
    Yang GT; Yao MY; Yang JJ; Yuan Z; Liu J; Huo MD; Zhang XW
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):523-5. PubMed ID: 16078672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.